These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31498178)

  • 21. Diagnostic accuracy of pan-TRK immunohistochemistry in differentiating secretory carcinoma from acinic cell carcinoma of salivary gland-A systematic review.
    Sharma P; Sivakumar N; Pandiar D
    J Oral Pathol Med; 2023 Mar; 52(3):255-262. PubMed ID: 36207812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammary analogue secretory carcinoma of salivary glands: a new entity associated with ETV6 gene rearrangement.
    Majewska H; Skálová A; Stodulski D; Klimková A; Steiner P; Stankiewicz C; Biernat W
    Virchows Arch; 2015 Mar; 466(3):245-54. PubMed ID: 25503077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammary analogue secretory carcinoma of salivary glands: a clinicopathologic and molecular study including 2 cases harboring ETV6-X fusion.
    Ito Y; Ishibashi K; Masaki A; Fujii K; Fujiyoshi Y; Hattori H; Kawakita D; Matsumoto M; Miyabe S; Shimozato K; Nagao T; Inagaki H
    Am J Surg Pathol; 2015 May; 39(5):602-10. PubMed ID: 25651470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-tumor screening for NTRK gene fusions using pan-TRK immunohistochemistry and RNA NGS fusion panel testing.
    Koehne de González A; Mansukhani MM; Fernandes H; Hsiao SJ
    Cancer Genet; 2022 Apr; 262-263():47-52. PubMed ID: 35007853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics.
    Hung YP; Fletcher CDM; Hornick JL
    Histopathology; 2018 Oct; 73(4):634-644. PubMed ID: 29863809
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of mammary analogue secretory carcinoma of the salivary gland: discrimination from its mimics by the presence of the ETV6-NTRK3 translocation and novel surrogate markers.
    Urano M; Nagao T; Miyabe S; Ishibashi K; Higuchi K; Kuroda M
    Hum Pathol; 2015 Jan; 46(1):94-103. PubMed ID: 25456394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
    Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
    Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretory carcinoma of the sinonasal cavity and pharynx: A retrospective analysis of four cases and literature review.
    Yue C; Zhao X; Ma D; Piao Y
    Ann Diagn Pathol; 2022 Dec; 61():152052. PubMed ID: 36270241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian Multicentric Pan-TRK (CANTRK) Immunohistochemistry Harmonization Study.
    Hyrcza MD; Martins-Filho SN; Spatz A; Wang HJ; Purgina BM; Desmeules P; Park PC; Bigras G; Jung S; Cutz JC; Xu Z; Berman DM; Sheffield BS; Cheung CC; Leduc C; Hwang DM; Ionescu D; Klonowski P; Chevarie-Davis M; Chami R; Lo B; Stockley TL; Tsao MS; Torlakovic E
    Mod Pathol; 2024 Jan; 37(1):100384. PubMed ID: 37972928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade salivary gland carcinoma with the ETV6-NTRK3 gene fusion: A case report and literature review of secretory carcinoma with high-grade transformation.
    Asai S; Sumiyoshi S; Yamada Y; Tateya I; Nagao T; Minamiguchi S; Haga H
    Pathol Int; 2021 Jun; 71(6):427-434. PubMed ID: 33848386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
    Makretsov N; He M; Hayes M; Chia S; Horsman DE; Sorensen PH; Huntsman DG
    Genes Chromosomes Cancer; 2004 Jun; 40(2):152-7. PubMed ID: 15101049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas.
    Zhang Z; Pang J; Chen L; Chen J; Li J; Liu H; Wang J; Wu H; Liang Z
    Hum Pathol; 2022 Nov; 129():21-31. PubMed ID: 35977594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Profiling of Mammary Analog Secretory Carcinoma Revealed a Subset of Tumors Harboring a Novel ETV6-RET Translocation: Report of 10 Cases.
    Skalova A; Vanecek T; Martinek P; Weinreb I; Stevens TM; Simpson RHW; Hyrcza M; Rupp NJ; Baneckova M; Michal M; Slouka D; Svoboda T; Metelkova A; Etebarian A; Pavelka J; Potts SJ; Christiansen J; Steiner P; Michal M
    Am J Surg Pathol; 2018 Feb; 42(2):234-246. PubMed ID: 29076873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pan-TRK Immunohistochemistry and NTRK Gene Fusions in Primary Carcinomas of the Liver.
    Zhang D; Liao X
    Appl Immunohistochem Mol Morphol; 2022 Jul; 30(6):435-440. PubMed ID: 35587529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.
    Rooper LM; Karantanos T; Ning Y; Bishop JA; Gordon SW; Kang H
    Am J Surg Pathol; 2018 Aug; 42(8):1121-1126. PubMed ID: 29683815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ETV6 Gene Rearrangements Characterize a Morphologically Distinct Subset of Sinonasal Low-grade Non-intestinal-type Adenocarcinoma: A Novel Translocation-associated Carcinoma Restricted to the Sinonasal Tract.
    Andreasen S; Skálová A; Agaimy A; Bishop JA; Laco J; Leivo I; Franchi A; Larsen SR; Erentaite D; Ulhøi BP; von Buchwald C; Melchior LC; Michal M; Kiss K
    Am J Surg Pathol; 2017 Nov; 41(11):1552-1560. PubMed ID: 28719468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemistry as a screening tool for NTRK gene fusions: results of a first Belgian ring trial.
    De Winne K; Sorber L; Lambin S; Siozopoulou V; Beniuga G; Dedeurwaerdere F; D'Haene N; Habran L; Libbrecht L; Van Huysse J; Weynand B; Wouters K; Pauwels P; Zwaenepoel K
    Virchows Arch; 2021 Feb; 478(2):283-291. PubMed ID: 32915263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation and interpretation of Pan-TRK immunohistochemistry: a practical approach and challenges with interpretation.
    Karakas C; Giampoli EJ; Love T; Hicks DG; Velez MJ
    Diagn Pathol; 2024 Jan; 19(1):10. PubMed ID: 38200576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of an immunocytochemical analysis for pan-Trk in the cytodiagnosis of secretory carcinoma of the salivary gland.
    Ito H; Ishida M; Ebisu Y; Okano K; Sandoh K; Noda Y; Miyasaka C; Fujisawa T; Yagi M; Iwai H; Tsuta K
    Diagn Cytopathol; 2021 Aug; 49(8):E329-E335. PubMed ID: 33885200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.